A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumours

Fraunhofer Institut für Biomedizinische Technik, Ensheimer Strasse 48, 66386 St. Ingbert, Germany.
Cryobiology (Impact Factor: 1.64). 04/2009; 58(2):119-27. DOI: 10.1016/j.cryobiol.2008.11.005
Source: PubMed

ABSTRACT Cryopreservation of human tumour cells and tissue is a valuable tool for retrospective analysis and for the transport and handling of biopsy material. Tumour tissue consists of different cell types, which have different optimal freezing conditions, and extracellular matrix. A well-defined and authentic model system is required for developing new freezing protocols and media. This work describes the use of L929 and PC-3 spheroids as new model systems for freezing human tumours. Cell suspension and spheroids were frozen in different vessels (1 ml cryovials and a special, cryo-compatible 30 x 25 microl multi well plate) at slow rate (1 degrees C/min). Freezing media were combinations of culture or tumour transport medium (Liforlab) with the cryoprotective agents, Me(2)SO, trehalose and modified starch. We also present a new method of evaluating the viability of three dimensional multicellular systems to compare thawed spheroids objectively. Best viability (70%) of L929 spheroids occurred with a combination of Liforlab and starch hydrolysis product. The best cryopreservation results for spheroids were found with extracellular cryoprotectants, while optimum viability of single cells was achieved with Me(2)SO.

Download full-text


Available from: Alisa Katsen-Globa, Jan 20, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryopreservation is the only widely applicable method of storing vital cells for nearly unlimited periods of time. Successful cryopreservation is essential for reproductive medicine, stem cell research, cord blood storage and related biomedical areas. The methods currently used to retrieve a specific cell or a group of individual cells with specific biological properties after cryopreservation are quite complicated and inefficient. The present study suggests a new approach in cryopreservation, utilizing the Individual Cell-based Cryo-Chip (i3C). The i3C is made of materials having appropriate durability for cryopreservation conditions. The core of this approach is an array of picowells, each picowell designed to maintain an individual cell during the severe conditions of the freezing--thawing cycle and accompanying treatments. More than 97% of cells were found to retain their position in the picowells throughout the entire freezing--thawing cycle and medium exchange. Thus the comparison between pre-freezing and post-thawing data can be achieved at an individual cell resolution. The intactness of cells undergoing slow freezing and thawing, while residing in the i3C, was found to be similar to that obtained with micro-vials. However, in a fast freezing protocol, the i3C was found to be far superior. The results of the present study offer new opportunities for cryopreservation. Using the present methodology, the cryopreservation of individual identifiable cells, and their observation and retrieval, at an individual cell resolution become possible for the first time. This approach facilitates the correlation between cell characteristics before and after the freezing--thawing cycle. Thus, it is expected to significantly enhance current cryopreservation procedures for successful regenerative and reproductive medicine.
    BMC Cell Biology 07/2010; 11:54. DOI:10.1186/1471-2121-11-54 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary cultures of brain cell neurospheres are valuable in vitro models for neurotoxicology and brain cell research. Such applications would greatly benefit from the development of efficient cryopreservation protocols that assure the availability of viable and genetically stable stocks of functional neurospheres. In this work we aimed at developing an integrated strategy allowing for long-term culture and cryopreservation of brain cell neurospheres with high viability and reduced recovery time postthawing. Microencapsulation in clinical-grade, ultrahigh viscous, highly purified alginate uniformly cross-linked with Ba(2+) was evaluated as the main strategy to avoid the commonly observed loss of cell-cell and cell-matrix interactions with consequent aggregate's fragmentation and decrease in cell viability that occurs postthawing. Brain cells isolated from 16-day-old fetal rats were cultured in spinner vessels as neurospheres, encapsulated at the 5th day of culture, and cryopreserved at day 19. Culture characterization and assessment of postthawing recovery, concerning cell metabolism, aggregate's cell type composition, and neuron-astrocyte interactions were performed through analysis of membrane integrity, metabolic activity assays, and immunohistochemistry. Our results show that the encapsulation process does not affect cell viability's central metabolism; neither cell differentiation nor cell extensions into cell networks are usually observed between neurons and astrocytes within the neurosphere structure. Neurosphere encapsulation resulted in reduced recovery time postthawing and significantly less fragmentation. Further, the use of serum-free CryoStor™ solution provided further protection for both nonencapsulated and encapsulated aggregates compared with serum-supplemented culture medium as the cryopreservation medium.
    Tissue Engineering Part C Methods 12/2009; 16(5):965-77. DOI:10.1089/ten.TEC.2009.0660 · 4.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The treatment of malignant brain tumors, especially of high-grade gliomas, poses one of the major challenges in cancer therapy. Despite seminal advancements in imaging techniques for the early diagnosis of CNS neoplasms as well as amendments in surgery and radiooncology, the prognosis of patients with glioma is very poor. The administration of temozolomide adjuvant to irradiation after resection of the tumor - the current “gold standard” in the treatment of glioblastoma - has only marginally improved median survival by ca. 3 months. Hence, there is an urgent need for novel approaches to the treatment of malignant brain tumors. To investigate the efficiency of such regimens in vivo, predictive preclinical animal models are indispensible. In this thesis, three subject areas were dealt with: - evaluation of doxorubicin-loaded poly(butylcyanoacrylate) (PBCA) nanoparticle (NP) formulations as drug-carriers, - modulation of the ATP-binding cassette transporter ABCG2, which is expressed in brain capillaries, by newly synthesized inhibitors, as a strategy to overcome the blood-brain barrier (BBB) with chemotherapeutics, which are substrates of this efflux pump, and - refinement of orthotopic glioblastoma models in nude mice to allow noninvasive optical imaging of intracerebral tumors. Human glioblastoma cells U-87 MG, U-118 MG and U-373 MG were incubated with free doxorubicin and doxorubicin loaded onto PBCA NPs. As the glioblastoma cells do neither express ABCB1 nor ABCG2, Kb-V1 and MCF-7/Topo cells were included, to study effects on both efflux pumps. In the crystal-violet chemosensitivity assay, cytotoxicities of the doxorubicin-loaded NPs and of the dissolved cytostatic were similar against all glioblastoma cells. By contrast, a higher efficacy of the NP formulations was observed on ABCB1-overexpressing Kb-V1, but not on ABCG2-expressing MCF-7/Topo cells, indicating an interaction of the NPs with the ABCB1 efflux pump. Therefore, increased drug concentrations in the brain after administration of such drug-loaded NPs to animals, as reported in literature, might be due interactions of the NPs with ABCB1 at the BBB. The modulation of ABC transporters at the BBB represents an attractive strategy to increase intracerebral levels of drugs, which are known to be substrates of such efflux pumps. For this reason, the identification of potent efflux pump inhibitors is a promising approach to improve the chemotherapy of brain tumors. A series of analogs, derived from the original ABCB1 inhibitor tariquidar, was investigated for potency against ABCG2 and selectivity vs. ABCB1. To expand methodology and to by-pass problems associated with the flow cytometric (FACS) mitoxantrone-efflux assay, two 96-well plate assays, using the fluorescent ABCG2 substrates Hoechst 33342 and pheophorbide a, were developed. Interestingly, slight structural modifications of tariquidar analogs yielded potent and selective inhibitors of ABCG2. The most potent modulator showed an IC50 value of 60 nM in the FACS assay and 65 and 126 nM in the microtiter plate assays. In view of future in vivo studies, the most potent inhibitors were investigated for stability in plasma by the means of HPLC-MS analysis. Unfortunately, these compounds are prone to rapid enzymatic cleavage at the central benzamide moiety. Therefore, compounds with improved drug-like properties are required. Since a regulation of ABCG2 by estrogens is discussed in literature, MCF-7/Topo cells were treated with estradiol and subjected to treatment with topotecan. No differences in the antiproliferative effect between estradiol-treated and non-treated controls were observed, indicating, at best, a therapeutically irrelevant regulation of the ABCG2-level by estradiol. To investigate the therapeutic value of new concepts, e.g. the combined administration of selective inhibitors of ABC-transporters with appropriate cytostatics, the main focus of this work was the refinement of in vivo xenograft models. Indeed, orthotopic brain tumor models, allowing the monitoring of tumor progression by noninvasive optical imaging, were established in nude mice. For this purpose, human U-87 MG glioblastoma cells were transfected with the genes encoding luciferase2 (Luc2) and the recently discovered far-red fluorescent protein Katushka (Kat), respectively. Numerous clones were characterized in vitro with respect to bioluminescence / fluorescence, growth kinetics and chemosensitivity. As the transfectants were tumorigenic subcutaneously (s.c.), and Luc2 as well as Kat expression persisted in the s.c. model, the human glioblastoma variants were injected into the brains of nude mice, where reproducibly growing tumors developed. Most important is the fact that these intracerebral xenografts were accessible to both, bioluminescence and fluorescence imaging. Moreover, there was a direct correlation between the optical signals and the tumor load, confirmed by histology.